Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01292928 · ClinicalTrials.gov registry record · NA
SuperNOVA Clinical Stenting Trial
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 299
- Enrollment target
NCT01292928 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 299 participants.
The verdict
NCT01292928, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 299 participants
- Enrollment target
Study Summary
The primary objective of this clinical study is to determine whether the Innova Stent System shows acceptable performance in long-term (12-month) safety rates and vessel patency when treating femoropopliteal lesions.
Interventions
- DEVICE Stent implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 299 participants |
| Start Date | 2011-04 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01292928
The ClinicalTrials.gov registry entry for NCT01292928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 299 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Stent implantation is the first listed.
NCT01292928 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01292928 about?
NCT01292928 is a clinical study titled "SuperNOVA Clinical Stenting Trial". The primary objective of this clinical study is to determine whether the Innova Stent System shows acceptable performance in long-term (12-month) safety rates and vessel patency when treating femoropopliteal lesions.
What is the current status of trial NCT01292928?
This trial is currently completed. It is a NA study. The enrollment target is 299 participants. The study started on 2011-04. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01292928?
The interventions under investigation include: Stent implantation (DEVICE).
Who is sponsoring clinical trial NCT01292928?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.